‘Two different results’ of Xtandi vs Zytiga

Published: 2014-10-23 16:26:00
Updated: 2014-10-23 14:10:27

New drugs for late state prostate cancer had two different results.

While Astellas Pharmaceutical’s ‘Xtandi Capsule(Enzalutamide)’ is registered on the positive list, Janssen’s ‘Zytiga Tab(Abiraterone Acetate)’ could not get on the list.

According to the industry related to Ministry of Health a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.